Go Back to Match Results for ""

Genotype-directed Phase II Study of Irinotecan Dosing in Metastatic Colorectal Cancer (mCRC) Patients Receiving FOLFIRI + Bevacizumab
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required